# MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis

> **NCT04276740** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Edinburgh** · enrollment: 79 (actual)

## Conditions studied

- Ulcerative Colitis Flare

## Interventions

- **DIETARY_SUPPLEMENT:** MitoQ
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04276740
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-31
- **Primary completion:** 2025-12-14
- **Final completion:** 2026-11-30
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2026-01-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04276740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04276740, "MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04276740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*